| abstract |
Provided herein are methods for identifying a subject at risk of breast cancer or prostate cancer, methods for providing a prognosis to a subject at risk of breast cancer or suffering from breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer or prostate cancer, and therapeutic methods for treating breast cancer or prostate cancer in a subject. These embodiments are based upon and analysis of polymorphic variations in nucleotide sequences within the human genome. |